A 12-Week, Phase 2 Study of Gemcabene in Hypercholesterolemia Patients on Stable Moderate and High-Intensity Statins
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 105 participants.
Also called NCT02634151
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 105 participants
- Sponsor
- NeuroBo Pharmaceuticals Inc.
- Registry
-
NCT02634151
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT02634151. Randomized; quadruple masking; primary purpose treatment. Start 2016-11 (registry gives no type); primary completion 2017-06 (actual). Results posted on 2020-06-25.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A 12-Week, Phase 2 Study of Gemcabene in Hypercholesterolemia Patients on Stable Moderate and High-Intensity Statins
- Acronym
- ROYAL-1
- Condition
- Hypercholesteremia
- Intervention (Drug)
- Gemcabene
- Intervention (Drug)
- Placebo
- Lead sponsor
- NeuroBo Pharmaceuticals Inc.
Record details
- Record id
cardio:ct-nct02634151- Content hash
7a63dc1089e475d5f5a4b80b7b4eda29a256e08a89ed0610f7ef1b4758266c89